Trends in utilization of oncology drugs for Medicare fee-for-service beneficiaries from 2002 through 2009.

e16625 Background: Medicare expenditures and the use of oncology drugs have increased over time. Shahinian, VB, et al (NEJM 2010) determined that changes in Medicare reimbursement policy in 2004 an...